On sonography, liver shows increased echogenicity both in glycogen storage diseases and steatosis. Liver hyperechogenicity in glycogen storage diseases may depend on accumulation of glycogen and/or fat. Chemical-shift magnetic resonance imaging can discriminate tissues only containing water from those ...
Moderappears as increased liver echogenicity that obscures the hepatic and portal vein walls (Figure 1). In severe steatosis, there is posterior attenuation of the deep liver parenchyma, which is useful in diagnosing steatosis of more than 30%.34 However, the ultrasonographic evaluation of ...
Infiltration within the liver occurs predominantly along the sinusoids and results in the non-specific signs of hepatomegaly, increased echogenicity at US with hypoattenuation at CT mimicking steatosis and heterogeneous enhancement following contrast medium administration. Elastography demonstrates increased ...
normal, steatosis, chronic hepatitis without cirrhosis, compensated cirrhosis, decompensated cirrhosis, and HCC. In Fig.3, an year-wise number of studies is shown. The plot shows an increasing trend in the number of studies over
A: sagittal image of the right lobe (RL) of the liver demonstrating the normal increased echogenicity relationship between the normal liver and normal right kidney (RK). B: A transverse image demonstrating the normal homogeneous echo pattern of the liver and the three main hepatic veins, the ...
Autoimmune hepatitis: Consider a trial ofsteroidson a case-by-case basis, weighing the increased risk of infection against the likely benefit. Viralhepatitis:supportive treatment and antivirals, depending on the cause (e.g.,HBV infection,HSVhepatitis) ...
1 Our result showed neither C-CEUS nor H-CEUS had a significant influence on wash-out, which demonstrated that H-CEUS had not increased the destruction of contrast agents. More malignant lesions showed centripetal and peripheral enhancement on H-CEUS than that on C-CEUS (51 vs. 13). ...
(liver, gallbladder, pancreas, and spleen) was performed by well-trained operators who were blind to the laboratory and clinical data. Diagnostic criteria of fatty liver are as follows: (i) increased liver brightness; (ii) diffuse hyperechogenicity of the liver compared to the kidneys; (iii)...
There may be a diffuse increased echogenicity and consequently poor definition of the portal vessels. Changes in echotexture and echogenicity fall broadly into the categories of diffuse or focal changes, with hyperechoic or hypoechoic features. The liver margins should be examined for changes in contou...
Chemotherapy-associated steatohepatitis (CASH) may be diffuse or focal and can be seen on ultrasound (US) as increased parenchymal echogenicity and beam attenuation [3]. Steatosis may also be visualised on computed tomography (CT) and is characterised by decreased parenchymal attenuation (Fig.1) [...